{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T08:32:51Z","timestamp":1770712371817,"version":"3.49.0"},"reference-count":38,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T00:00:00Z","timestamp":1738886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background\/Objectives: Myelodysplastic syndromes (MDS) are clonal hematopoietic disorders characterized by ineffective hematopoiesis and a risk of progression to acute myeloid leukemia (AML). Cognitive impairments, including deficits in memory, attention, and executive function, are frequently reported in MDS patients. These impairments are linked to systemic inflammation, neurotoxic treatment effects, and the psychological burden of chronic disease. This review synthesizes existing evidence on cognitive dysfunction in MDS, highlighting knowledge gaps and opportunities for future research. Methods: A scoping review was conducted following PRISMA-ScR guidelines. MEDLINE and Scopus databases were searched for studies examining cognition in MDS patients, using terms like \u201cmyelodysplastic syndromes\u201d and \u201ccognition.\u201d Inclusion criteria were original, English-language studies reporting cognitive outcomes in MDS. Reviews, animal studies, and abstracts were excluded. Data on study design, patient characteristics, cognitive tests, and outcomes were extracted and descriptively analyzed. Results: The review included 25 studies involving 2390 patients with hematologic malignancies, 493 of whom had MDS. Key findings identified cognitive deficits primarily in attention, executive function, and memory. Systemic inflammation and treatment-related neurotoxicity were significant contributors, with older age compounding these effects. Longitudinal studies demonstrated persistent cognitive challenges post-treatment, though the severity varied by patient demographics and therapeutic regimens. Conclusions: Cognitive impairments in MDS are multifactorial and significantly impact patients\u2019 quality of life. Current research highlights the need for routine cognitive assessments and targeted interventions. Future studies should focus on longitudinal designs to explore specific cognitive domains and develop therapeutic strategies to mitigate cognitive decline.<\/jats:p>","DOI":"10.3390\/medsci13010015","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T09:02:42Z","timestamp":1738918962000},"page":"15","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Scoping Review on Cognition in Myelodysplastic Syndromes: Advances and Challenges"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3341-4093","authenticated-orcid":false,"given":"Anna","family":"Tsiakiri","sequence":"first","affiliation":[{"name":"Department of Neurology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Frigkas","sequence":"additional","affiliation":[{"name":"Department of Radiology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8828-9093","authenticated-orcid":false,"given":"Pinelopi","family":"Vlotinou","sequence":"additional","affiliation":[{"name":"Department of Occupational Therapy, University of West Attica, 12243 Athens, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menelaos","family":"Papoutselis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Foteini","family":"Christidi","sequence":"additional","affiliation":[{"name":"Department of Neurology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Efstratios","family":"Karavasilis","sequence":"additional","affiliation":[{"name":"Medical Physics Laboratory, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7668-0186","authenticated-orcid":false,"given":"Ioannis","family":"Kotsianidis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos","family":"Kourkoutsakis","sequence":"additional","affiliation":[{"name":"Department of Radiology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Vadikolias","sequence":"additional","affiliation":[{"name":"Department of Neurology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantinos","family":"Liapis","sequence":"additional","affiliation":[{"name":"Department of Hematology, Democritus University of Thrace, 68100 Alexandroupolis, Greece"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,7]]},"reference":[{"key":"ref_1","first-page":"783","article-title":"Myelodysplastic Syndromes: Diagnosis, Prognosis, and Treatment","volume":"110","author":"Germing","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/bjh.14211","article-title":"What Is Known and Unknown about Chemotherapy-Related Cognitive Impairment in Patients with Haematological Malignancies and Areas of Needed Research","volume":"174","author":"Williams","year":"2016","journal-title":"Br. J. Haematol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"238","DOI":"10.3390\/neurolint15010016","article-title":"Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review","volume":"15","author":"Tziaka","year":"2023","journal-title":"Neurol. Int."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11682-013-9250-3","article-title":"Chemotherapy-Related Cognitive Dysfunction: Current Animal Studies and Future Directions","volume":"7","author":"Seigers","year":"2013","journal-title":"Brain Imaging Behav."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1517\/13543784.2011.559164","article-title":"Epigenetic Regulation in Myelodysplastic Syndromes: Implications for Therapy","volume":"20","author":"Vigna","year":"2011","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.critrevonc.2019.06.002","article-title":"Hematologic Improvement with Iron Chelation Therapy in Myelodysplastic Syndromes: Clinical Data, Potential Mechanisms, and Outstanding Questions","volume":"141","author":"Leitch","year":"2019","journal-title":"Crit. Rev. Oncol.\/Hematol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/annonc\/mdz410","article-title":"Cancer-Related Cognitive Impairment: An Update on State of the Art, Detection, and Management Strategies in Cancer Survivors","volume":"30","author":"Lange","year":"2019","journal-title":"Ann. Oncol."},{"key":"ref_8","first-page":"6960","article-title":"Clonal Hematopoiesis of Indeterminate Potential Is Associated with Reduced Risk of Cognitive Impairment in Patients with Chronic Kidney Disease","volume":"20","author":"Xiao","year":"2024","journal-title":"Alzheimer\u2019s Dement."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1159\/000489042","article-title":"ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications","volume":"86","author":"Valent","year":"2018","journal-title":"Pathobiology"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40291-024-00737-7","article-title":"Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP","volume":"28","author":"Skov","year":"2024","journal-title":"Mol. Diagn. Ther."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal Hematopoiesis of Indeterminate Potential and Its Distinction from Myelodysplastic Syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.7326\/M18-0850","article-title":"PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann. Intern. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.bbi.2019.04.008","article-title":"Worsening Cognitive Performance Is Associated with Increases in Systemic Inflammation Following Hematopoietic Cell Transplantation","volume":"80","author":"Hoogland","year":"2019","journal-title":"Brain Behav. Immun."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/cncr.21234","article-title":"Cognitive Impairment, Fatigue, and Cytokine Levels in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome","volume":"104","author":"Meyers","year":"2005","journal-title":"Cancer"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"498.e1","DOI":"10.1016\/j.jtct.2022.05.018","article-title":"Geriatric Assessment Reveals Actionable Impairments in Hematopoietic Stem Cell Transplantation Candidates Age 18 to 80 Years","volume":"28","author":"Lew","year":"2022","journal-title":"Transplant. Cell. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jgo.2019.11.007","article-title":"Screening for Cognitive Impairment in Older Adults with Hematological Malignancies Using the Montreal Cognitive Assessment and Neuropsychological Testing","volume":"11","author":"Koll","year":"2020","journal-title":"J. Geriatr. Oncol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.bbmt.2017.08.006","article-title":"The Role of Age in Neurocognitive Functioning among Adult Allogeneic Hematopoietic Cell Transplant Recipients","volume":"23","author":"Hoogland","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s40001-023-01145-z","article-title":"Exercise and Epigenetic Ages in Older Adults with Myeloid Malignancies","volume":"28","author":"Loh","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00520-020-05697-2","article-title":"Cognitive Function in Patients Prior to Undergoing Allogeneic Hematopoietic Stem Cell Transplantation","volume":"29","author":"Nakamura","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/ajh.22151","article-title":"Association of Anemia and Cognitive Dysfunction in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome","volume":"86","author":"Wood","year":"2011","journal-title":"Am. J. Hematol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1176\/appi.neuropsych.12070177","article-title":"Cognitive and Other Predictors of Change in Quality of Life One Year after Treatment for Chronic Myelogenous Leukemia or Myelodysplastic Syndrome","volume":"26","author":"Chang","year":"2014","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wall, S.A., Huang, Y., Keiter, A., Funderburg, A., Kloock, C., Yuhasz, N., Gure, T.R., Folefac, E., Stevens, E., and Presley, C.J. (2021). Integration of a Geriatric Assessment with Intervention in the Care of Older Adults with Hematologic Malignancies. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.775050"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00520-020-05458-1","article-title":"Cognitive Complaints by Hematopoietic Cell Transplantation Recipients and Change in Neuropsychological Performance over Time","volume":"29","author":"LaLonde","year":"2021","journal-title":"Support. Care Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1093\/arclin\/acs141","article-title":"Predictors of Neuropsychological Change in Patients with Chronic Myelogenous Leukemia and Myelodysplastic Syndrome","volume":"28","author":"Meadows","year":"2013","journal-title":"Arch. Clin. Neuropsychol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1002\/cncr.24496","article-title":"Mental Status Changes after Hematopoietic Stem Cell Transplantation","volume":"115","author":"Chang","year":"2009","journal-title":"Cancer"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s00277-013-2001-0","article-title":"The G8 Screening Tool Detects Relevant Geriatric Impairments and Predicts Survival in Elderly Patients with a Haematological Malignancy","volume":"93","author":"Hamaker","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/pon.3159","article-title":"Cognitive Functioning in Allogeneic Hematopoietic Stem Cell Transplantation Recipients and Its Medical Correlates: A Prospective Multicenter Study","volume":"22","author":"Scherwath","year":"2013","journal-title":"Psycho-Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1007\/s00277-014-2070-8","article-title":"Biosimilar Epoetin in Elderly Patients with Low-Risk Myelodysplastic Syndromes Improves Anemia, Quality of Life, and Brain Function","volume":"93","author":"Castelli","year":"2014","journal-title":"Ann. Hematol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1080\/10428194.2020.1747063","article-title":"Comorbidities Cluster with Impaired Functional Capacities and Depressive Mood and Predict Adverse Outcome in Older Patients with Hematological Malignancies","volume":"61","author":"Nagl","year":"2020","journal-title":"Leuk. Lymphoma"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.bmt.1705884","article-title":"Rehabilitation of Therapy-Related Cognitive Deficits in Patients after Hematopoietic Stem Cell Transplantation","volume":"41","author":"Poppelreuter","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"468.e1","DOI":"10.1016\/j.jtct.2023.03.026","article-title":"Cognitive Functioning in Survivors of Hematopoietic Stem Cell Transplantation Compared With a Matched General Population Sample\u2014The Maastricht Observational Study of Late Effects After Stem Cell trAnsplantation Study","volume":"29","author":"Wauben","year":"2023","journal-title":"Transplant. Cell. Ther."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/sj.bmt.1705663","article-title":"Cognitive Function in the Acute Course of Allogeneic Hematopoietic Stem Cell Transplantation for Hematological Malignancies","volume":"39","author":"Mehnert","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jgo.2019.05.022","article-title":"The Use of Comprehensive Geriatric Assessment in Older Patients before Allologeneic Hematopoietic Stem Cell Transplantation: A Cross-Sectional Study","volume":"11","author":"Rodrigues","year":"2020","journal-title":"J. Geriatr. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"771","DOI":"10.21873\/invivo.11837","article-title":"Importance of Monitoring Physical Function for Quality of Life Assessments in Hematopoietic Stem Cell Transplantation Patients: A Prospective Cohort Study","volume":"34","author":"Kim","year":"2020","journal-title":"In Vivo"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000022185","article-title":"Prevalence and Survival of Myelodysplastic Syndrome of the Refractory Anemia Type in Hospitalized Cognitively Different Geriatric Patients","volume":"46","author":"Beloosesky","year":"2000","journal-title":"Gerontology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s41983-019-0104-9","article-title":"Chemotherapy-Induced Cognitive Impairment in Hematological Malignancies","volume":"55","author":"Kotb","year":"2019","journal-title":"Egypt. J. Neurol. Psychiatry Neurosurg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jgo.2019.02.002","article-title":"Comprehensive Geriatric Assessment Predicts Azacitidine Treatment Duration and Survival in Older Patients with Myelodysplastic Syndromes","volume":"11","author":"Molga","year":"2020","journal-title":"J. Geriatr. Oncol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3390\/neurolint16010014","article-title":"Processing Speed and Attentional Shift\/Mental Flexibility in Patients with Stroke: A Comprehensive Review on the Trail Making Test in Stroke Studies","volume":"16","author":"Tsiakiri","year":"2024","journal-title":"Neurol. Int."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/15\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:28:46Z","timestamp":1760027326000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/13\/1\/15"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,7]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["medsci13010015"],"URL":"https:\/\/doi.org\/10.3390\/medsci13010015","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,7]]}}}